A Phase II Trial of TAS-102 (Lonsurf) in Patients With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma After Progression Through First Line Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2018
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 06 Aug 2018 Planned number of patients changed from 50 to 40.
- 14 Dec 2017 Planned number of patients changed from 33 to 50.
- 06 Nov 2017 Planned End Date changed from 1 Oct 2020 to 1 Nov 2020.